icotrokinra
icotrokinra is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including ICOTYDE. Available dosage form: tablet, film coated.
Drug Details
- Generic Name
- icotrokinra
- Brand Names
- ICOTYDE
- Application Number
- NDA220149
- Sponsor
- Janssen Biotech, Inc.
- NDC Codes
- 1
- Dosage Forms
- TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- ICOTROKINRA
Indications and Usage
1 INDICATIONS AND USAGE ICOTYDE is indicated for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients 12 years of age and older who weigh at least 40 kg who are candidates for systemic therapy or phototherapy. ICOTYDE is an interleukin-23 (IL-23) receptor antagonist indicated for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients 12 years of age and older who weigh at least 40 kg who are candidates for systemic therapy or phototherapy. ( 1 )